The use of immunotherapy for the treatment of refractory forms of Hodgkin lymphoma in real clinical practice.

The use of immunotherapy for the treatment of refractory forms of Hodgkin lymphoma in real clinical practice.

With a frequency of 2.2 cases per 100,000 population in Russia, Hodgkin's lymphoma (HL) is one of the most common malignant neoplasms in young people. In connection with the predominant spread of HL among young people, the issue of effective treatment of various forms of HL remains relevant. Cu...

Full description

Saved in:
Bibliographic Details
Main Authors: I. A. Kamaeva, I. B. Lysenko, N. V. Nikolaeva, T. F. Pushkareva, E. A. Kapuza, Ya. S. Gaisultanova, A. V. Velichko
Format: Article
Language:Russian
Published: ANO "Perspective of oncology" 2021-06-01
Series:Южно-Российский онкологический журнал
Subjects:
hodgkin lymphoma
immunotherapy
refractory
relapse
targeted therapy
clinical experience
Online Access:https://www.cancersp.com/jour/article/view/99
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items